Related Experiment Video
Updated: Jun 8, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Regulating direct-to-consumer genetic tests: what is all the fuss about?
Caroline F Wright1, Alison Hall, Ron L Zimmern
1PHG Foundation, Cambridge, United Kingdom. caroline.wright@phgfoundation.org
Stricter regulation is needed for direct-to-consumer genetic tests. Five key requirements, including lab accreditation and clear consent, can protect consumers from potential harms of genetic testing.
Area of Science:
- Genetics
- Bioethics
- Regulatory Science
Background:
- The direct-to-consumer (DTC) genetic testing market has expanded rapidly.
- There is a growing demand for enhanced regulation of DTC genetic testing services.
- A lack of consensus exists regarding the appropriate level of regulation for this global market.
Purpose of the Study:
- To propose a feasible regulatory framework for DTC genetic tests.
- To address potential direct and indirect harms associated with genetic susceptibility and genomic profiling tests.
- To offer a model applicable to other forms of predictive genetic testing.
Main Methods:
- Analysis of potential harms from DTC genetic testing.
- Development of a regulatory framework based on key consumer protection principles.
- Consideration of the global nature of the DTC genetic testing market.
Main Results:
- A framework with five core requirements is proposed for effective DTC genetic test regulation.
- These requirements aim to safeguard consumers from inaccurate or misleading genetic information.
- The proposed framework is adaptable to various predictive testing scenarios.
Conclusions:
- Five essential requirements can adequately protect consumers using DTC genetic tests.
- Key recommendations include proportionate consent, laboratory accreditation, validated gene-disease associations, qualified interpretation staff, and robust consumer protection legislation.
- Implementing these measures can enhance the safety and reliability of the DTC genetic testing industry.
More Related Videos
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Related Concept Videos
What is Genetic Engineering?
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Drug Regulation
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
CRISPR